Clinical Lecturer, Yong Loo Lin School of Medicine, National University of Singapore
Multiple Myeloma, Amyloidosis, Lymphoma
Dr Cinnie Yentia Soekojo is
an Associate Consultant at the National University Cancer Institute,
Singapore. She completed
her Internal Medicine residency at the National University Hospital,
Singapore and obtained her post-graduate qualification from the Royal Colleges
of Physicians, United Kingdom. She continued with her advanced specialty training
in Haematology at the National University Cancer Institute, Singapore and
Fellowship of the Royal College of Pathologist, United Kingdom.
Her primary clinical and
research interests are in multiple myeloma and plasma cell disorders. She has
published in several peer-reviewed journals and has also presented at regional
and international meetings. She has received several awards and also holds
several grants for her research and is currently involved in clinical
trials and translational research in her field of interest.
She is also
active in undergraduate teaching and is a Clinical Lecturer at
the Yong Loo Lin School of Medicine, National University of Singapore.
2019 - NUS-ExxonMobil Research Fellowship for Clinicians
2018 - Clinicians Scientist Unit Pitch for Funds Award
2017 - Singapore Society of Haematology Annual Scientific Meeting Best Oral Presentation
2017 - NCIS Annual Research Meeting Best Poster Award in Malignant Haematology
American Society of Haematology
European Haematology Association
Singapore Society of Haematology
Kim K, Huang SY, Chim CS, Takezako N, Asaoku H, et al. Pomalidomide and
dexamethasone combination with additional cyclophosphamide in
relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma
Network. Blood Cancer J. 2019;9(10):83.
Wang GM, Chen Y, Casan J, Wolyncewicz G, Lin A, et al. Role of
Conventional Karyotyping in Multiple Myeloma in the Era of Modern
Treatment and FISH Analysis. Clinical lymphoma, myeloma & leukemia.
Low JZ, Oh J, Ooi M, De Mel S, Chng WJ. Bacterial Infection Amongst
Multiple Myeloma Patients Treated With Bortezomib- Based Induction
Therapy: Real-World Experience in an Asian Cancer Center. Clinical
Lymphoma Myeloma and Leukemia. 2020.
Kumar SK. Stem-cell transplantation in multiple myeloma: how far have we
come? Therapeutic advances in hematology. 2019;10:2040620719888111.
de Mel S, Ooi M, Yan B, Chng WJ. Potential Clinical Application of
Genomics in Multiple Myeloma. Int J Mol Sci. 2018;19(6).